Is It Time To Revisit Xylem (XYL) After Recent Share Price Weakness?
Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million individual investors worldwide.
If you are wondering whether Xylem is fairly priced at around US$120 or if the market is missing something in the story, this breakdown will help you weigh the current share price against the company’s fundamentals.
The stock is up 0.5% over the last 7 days, while showing a 6.8% decline over 30 days, a 12.2% decline year to date, and a 2.9% return over the past year. These moves can change how investors think about both risk and opportunity.
Recent coverage around Xylem has focused on its role in water technology and infrastructure solutions, as investors keep an eye on sectors linked to essential services. This backdrop helps explain why the share price has been relatively steady over 1 year despite shorter term swings.
Xylem currently has a valuation score of 5/6, which suggests many of the key checks flag it as potentially undervalued. The next sections will walk through different valuation approaches and then finish with a broader way to think about what the market is really pricing in.
The DCF model estimates what Xylem could be worth by projecting future cash flows and discounting them back to today’s value. It looks at the cash the business is expected to generate for shareholders and then works out what that stream is worth in present terms.
For Xylem, the model used is a 2 Stage Free Cash Flow to Equity approach. The latest twelve month Free Cash Flow is about $893.5 million. Analyst and extrapolated projections indicate Free Cash Flow reaching around $1.98 billion by 2030, with a series of annual estimates and extrapolations between 2026 and 2035 that Simply Wall St discounts back to today using its own assumptions.
Pulling those discounted projections together gives an estimated intrinsic value of about $158.51 per share. Compared with the current share price of around $120, the model implies the stock is 24.0% undervalued based purely on these cash flow assumptions.
For a company that is generating profits, the P/E ratio is a straightforward way to connect what you pay for the shares with the earnings each share produces. Investors usually accept a higher P/E when they expect stronger growth or see lower risk, and a lower P/E when they see weaker growth or higher risk, so there is no single “correct” number that fits every business.
Xylem currently trades on a P/E of 30.6x. That sits above the Machinery industry average of about 25.9x, but below the broader peer group average of 41.4x. On the surface, that suggests the market is pricing Xylem at a premium to its industry, yet not as highly as some peers in related areas.
Simply Wall St’s Fair Ratio for Xylem is 30.9x. This is a proprietary estimate of what the P/E might reasonably be, given factors such as earnings growth profile, industry, profit margins, market value and company specific risks. Because it adjusts for these elements, the Fair Ratio can be more informative than a simple comparison with industry or peer averages. Xylem’s current P/E of 30.6x is very close to the Fair Ratio of 30.9x, which suggests the shares are priced at about the level implied by those fundamentals.
Earlier it was mentioned that there is an even better way to understand valuation. Now it is time to introduce Narratives, which let you attach a clear story about Xylem to the numbers you think are reasonable for its future revenue, earnings, margins and fair value, then compare that Fair Value to today’s share price to assess whether the stock appears attractive or stretched.
On Simply Wall St’s Community page, Narratives are an accessible tool used by many investors to connect a company’s story to a financial forecast. This helps ensure your view is not just a guess about the future but a set of assumptions that can be recalculated automatically when new information such as earnings results, guidance, buybacks or analyst target changes is added.
For Xylem, one investor might build a Narrative similar to more bullish views, with revenue assumptions closer to US$10.1b, earnings of around US$1.4b and a Fair Value linked to a higher P/E. Another investor might lean toward a more cautious view, with revenue closer to US$9.6b, earnings around US$1.2b and a lower P/E. The platform then shows how each story translates into a Fair Value range compared with the current price so you can choose the Narrative that best fits your expectations.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
